RPL32P4

Across TCGA pan-cancer cohorts, RPL32P4 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated RPL32P4 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RPL32P4 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL32P4 expression acts as an unfavorable survival marker, although some lineages such as HNSC and BLCA show a favorable association.

OV, ACC, and HNSC are the cancer types where RPL32P4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Quartile	II,III,IV	0.289	0.415	<.001	104	view →
ACC	OS	Tertile	All	0.731	0.945	<.001	91	view →
HNSC	DFS	Quartile	All	0.703	0.564	.001	80	view →
CHOL	DFS	Tertile	All	0.028	0.524	<.001	45	view →
DLBC	DFS	Median	II,III,IV	0.567	0.971	.016	31	view →
LUSC	OS	Tertile	IV	0.057	0.786	.017	18	view →
BLCA	DFS	Median	III,IV	0.619	0.358	.001	11	view →
PAAD	DFS	Tertile	All	0.168	0.354	.015	8	view →
UVM	OS	Tertile	II,III,IV	0.875	0.519	.044	8	view →
READ	DFS	Quartile	III,IV	0.833	0.486	.023	8	view →
ESCA	DFS	Quartile	III,IV	0.590	0.277	.023	6	view →
KIRC	DFS	Tertile	All	0.944	0.827	.027	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

RPL32P4–OV (DFS)

Open the OV breakdown →